Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001226488-17-000005

Director sold 30,000 shares at an average $30.30 ($909,040)

  • Director acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

HENDERSON JOHN T · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2017-09-01 Exercise or conversion : show line 1 in the form +10,000 $16.46 $164,600 52,524 D
2017-09-01 Sale : show line 2 in the form −10,000 $30.31 $303,056 42,524 D
2017-09-01 Exercise or conversion : show line 3 in the form +10,000 $16.46 $164,600 52,524 D
2017-09-01 Sale : show line 4 in the form −10,000 $30.30 $303,003 42,524 D
2017-09-01 Exercise or conversion : show line 5 in the form +10,000 $16.46 $164,600 52,524 D
2017-09-01 Sale : show line 6 in the form −10,000 $30.30 $302,981 42,524 D
Open-market sales · 30,000 sh · avg $30.30 · $909,040

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-09-01 Exercise or conversion : show line 7 in the form Non-Qualified Stock Option (right to buy) −10,000 $16.46 2017-11-15 10,000 20,000 D
2017-09-01 Exercise or conversion : show line 8 in the form Non-Qualified Stock Option (right to buy) −10,000 $16.46 2017-11-15 10,000 10,000 D
2017-09-01 Exercise or conversion : show line 9 in the form Non-Qualified Stock Option (right to buy) −10,000 $16.46 2017-11-15 10,000 0 D
Loading xslF345X03/edgardoc.xml…